Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
9 min read
Tislelizumab in Unresectable Hepatocellular Carcinoma: NCT07535840 Clinical Landscape Report 2026
15 October 2026
NCT07535840 clinical landscape for Unresectable Hepatocellular Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white…
9 min read
HC-0301 in Advanced Hepatocellular Carcinoma: NCT07540832 Clinical Landscape Report 2026
15 October 2026
NCT07540832 clinical landscape for Advanced Hepatocellular Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white spa…
9 min read
OV-4071 in Parkinson Disease: ACTRN12626000481370 Clinical Landscape Report 2026
15 October 2026
ACTRN12626000481370 clinical landscape for Parkinson Disease: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
OV-4071 in Parkinson Disease: ACTRN12626000480381 Clinical Landscape Report 2026
15 October 2026
ACTRN12626000480381 clinical landscape for Parkinson Disease: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
IDE574 in MSS/pMMR/MSI-L Colorectal Carcinoma: NCT07540572 Clinical Landscape Report 2026
15 October 2026
NCT07540572 clinical landscape for MSS/pMMR/MSI-L Colorectal Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white s…
9 min read
Upadacitinib hemihydrate in Colitis, Ulcerative: NCT07546097 Clinical Landscape Report 2026
15 October 2026
NCT07546097 clinical landscape for Colitis, Ulcerative: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Measles, mumps and rubella vaccine(Merck Sharp & Dohme) in Pancreatic carcinoma non-resectable: NCT07539155 Clinical Landscape Report 2026
15 October 2026
NCT07539155 clinical landscape for Pancreatic carcinoma non-resectable: endpoints, sponsor, phase, geography, readouts, asset context and development white s…
9 min read
BPX-601 in Metastatic castration-resistant prostate cancer: NCT07543055 Clinical Landscape Report 2026
15 October 2026
NCT07543055 clinical landscape for Metastatic castration-resistant prostate cancer: endpoints, sponsor, phase, geography, readouts, asset context and develop…
9 min read
177Lu-FC516 in Prostatic Cancer: NCT07542379 Clinical Landscape Report 2026
15 October 2026
NCT07542379 clinical landscape for Prostatic Cancer: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Irinotecan Hydrochloride Lioposome in Pancreatic Cancer: NCT07542002 Clinical Landscape Report 2026
15 October 2026
NCT07542002 clinical landscape for Pancreatic Cancer: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Tiotropium Bromide in Pulmonary Disease, Chronic Obstructive: NCT07541378 Clinical Landscape Report 2026
15 October 2026
NCT07541378 clinical landscape for Pulmonary Disease, Chronic Obstructive: endpoints, sponsor, phase, geography, readouts, asset context and development whit…
9 min read
JANX014 in Metastatic castration-resistant prostate cancer: NCT07545811 Clinical Landscape Report 2026
15 October 2026
NCT07545811 clinical landscape for Metastatic castration-resistant prostate cancer: endpoints, sponsor, phase, geography, readouts, asset context and develop…